Integrated Annual Report

The report highlights 7% revenue growth to above R2 billion, a 28.7% Sanlam investment in AfroCentric Healthcare Assets, and the R401 million acquisition of Pharmacy Direct and Curasana. It also records the Group's entry into the healthcare supply chain through WAD Holdings and the award of new managed-care contracts. Governance disclosures emphasize the Board's ultimate oversight of a sustainable business and the role of the Social and Ethics Committee in monitoring ethics, employment equity, socioeconomic development and environmental impact.